The NeuroShirt, developed from Elitac Wearables in collaboration with the University Medical Centre Utrecht (NL), is a patent-pending smart shirt that helps guide neurosurgeons during complicated skull-base surgeries. It connects to the neuronavigation system and continuously indicates both the distance and direction of critical structures through haptic feedback (vibrations). ‘This way,’ the…
‘Bittium NeurOne is one of the quickest and most accurate EEG measuring devices in the world designed for clinical and research use,’ the manufacturer reports. ‘Bittium NeurOne system enables fully synchronised group measuring of up to 30 people simultaneously, for example in different types of psychological studies. ‘The solution is optimised for use with transcranial magnetic…
For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought. Their results could have important implications for the development of potential treatments.
At their workplace, neurosurgeons often have to make compromises since most ORs were not designed with the specific needs of their discipline in mind. To address this issue the University Hospital in Essen, Germany, equipped an OR especially for neuro- and spine surgery. The aim is nothing less than revolutionizing the field with the help of digitalisation and cutting-edge technology.
The mechanisms by which the body measures temperature and regulates its own body heat are vital, but still poorly understood. The discovery of the first heat sensor on nerve cells in the skin, for which the U.S. molecular biologist David Julius received this year's Nobel Prize for Medicine, was therefore pioneering. However, a very similar heat sensor, the protein TRPM2, is active not only in the…
A new study shows that women are underrepresented in stroke clinical trials relative to the number who have strokes in the general population. The research is published in Neurology, the medical journal of the American Academy of Neurology. “Making sure there are enough women in clinical studies to accurately reflect the proportion of women who have strokes may have implications for future…
Researchers at Lund University in Sweden have developed a completely new stimulation method, using ultra-thin microelectrodes, to combat severe pain. This provides effective and personalised pain relief without the common side effects from pain relief drugs. The study, which was conducted on rats, has been published in the research journal Science Advances.
Neuroscientists at Technische Universität Dresden discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the human brain and point of origin of visual difficulties in diseases such as dyslexia and glaucoma. The new method could provide an in-depth understanding of visual sensory processing in both health and disease in the near…
The first augmented reality (AR) spinal surgery in the world has taken place at the Norfolk and Norwich University Hospital (NNUH). Surgeons at NNUH utilised the latest video technology and augmented reality (AR) googles with the assistance of a neurosurgical colleague in Wales providing extra support with a complex spinal cord stimulation procedure. The NNUH is one of the biggest neuromodulation…
The Nobel Prize in Physiology or Medicine 2021 was awarded jointly to two scientists who made important discoveries regarding our receptors for temperature and touch. Our ability to sense heat, cold and touch is essential for survival and underpins our interaction with the world around us. In our daily lives we take these sensations for granted, but how are nerve impulses initiated so that…
In the fight against diseases like amyotrophic lateral sclerosis (ALS), biomedical engineering researchers at the University of Southern California have created a powerful lab model to better see how our muscles and neurons connect.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study. ALS is the commonest form of motor neuron disease - a progressive nervous system disease that destroys nerve cells responsible for voluntary movement such as walking and talking.
A new mechanism that stops the progression of Huntington’s disease in cells has been identified by scientists at the University of Cambridge and University College London (UCL), as part of their research groups at the UK Dementia Research Institute. Researchers say the breakthrough study, published in Cell Reports, could lead to much needed therapies for the rare genetic disease, which is…
Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate risk for suffering a recurrence, according to a new study presented at the European Stroke Organisation (ESO) Conference. Experts believe the study will help to identify the most important factors for preventing stroke recurrence and has the potential to help prevent many thousands of strokes a year…
Scientists are using artificial intelligence (AI) and the Cambridge-1 supercomputer to synthesise artificial 3-D MRI images of human brains and create models that show disease states across various ages and genders. The Synthetic Brain Project is focused on building deep learning models which have been developed by King’s College London (KCL) and NVIDIA data scientists and engineers as part of…
Roche announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen (previously IONIS-HTTRx and RG6042) in manifest Huntington’s disease (HD). The decision was based on the results of a pre-planned review of the data from the Phase III study conducted by an unblinded Independent Data Monitoring Committee (iDMC). The iDMC made its recommendation based on the…
A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial.
An EPFL scientist has found that brain fingerprints – or maps of the neural connections within our brain – can be used to detect a decline in cognitive ability. That’s because the fingerprints are harder to detect in people who already have mild cognitive impairment.
A novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. The study, led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine, offers new hope to those living with incurable genetic and neurodegenerative diseases.
